234 related articles for article (PubMed ID: 9541093)
1. Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year.
Mosca M; Tavoni A; Neri R; Bencivelli W; Bombardieri S
Lupus; 1998; 7(2):95-100. PubMed ID: 9541093
[TBL] [Abstract][Full Text] [Related]
2. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
[TBL] [Abstract][Full Text] [Related]
3. Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients.
Vaz CC; Couto M; Medeiros D; Miranda L; Costa J; Nero P; Barros R; Santos MJ; Sousa E; Barcelos A; Inês L
Clin Rheumatol; 2009 Aug; 28(8):915-21. PubMed ID: 19390908
[TBL] [Abstract][Full Text] [Related]
4. Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients.
Cavazzana I; Franceschini F; Belfiore N; Quinzanini M; Caporali R; Calzavara-Pinton P; Bettoni L; Brucato A; Cattaneo R; Montecucco C
Clin Exp Rheumatol; 2001; 19(4):403-9. PubMed ID: 11491495
[TBL] [Abstract][Full Text] [Related]
5. Undifferentiated connective tissue diseases (UCTD).
Mosca M; Tani C; Neri C; Baldini C; Bombardieri S
Autoimmun Rev; 2006 Nov; 6(1):1-4. PubMed ID: 17110308
[TBL] [Abstract][Full Text] [Related]
6. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
Bodolay E; Szegedi G
Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the evolution to defined connective tissue diseases of patients with "early unidifferentiated connective tissue diseases (UCTD)"].
Mosca M; Tani C; Neri C; Craig F; Della Rossa A; Baldini C; Talarico R; Carli L; Bombardieri S
Reumatismo; 2008; 60(1):35-40. PubMed ID: 18432323
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ro(SS-A) 52 kDa and 60 kDa specificities in undifferentiated connective tissue disease.
Belfiore N; Rossi S; Bobbio-Pallavicini F; Epis O; Caporali R; Montecucco C
Joint Bone Spine; 2000; 67(3):183-7. PubMed ID: 10875315
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
[TBL] [Abstract][Full Text] [Related]
10. Raynaud's phenomenon in undifferentiated connective tissue disease (UCTD).
De Angelis R; Cerioni A; Del Medico P; Blasetti P
Clin Rheumatol; 2005 Apr; 24(2):145-51. PubMed ID: 15351873
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of pregnancy outcomes, disease progression, and risk factors in patients with undifferentiated connective tissue disease].
You FN; Luo L; Liu XJ; Zhang XW; Li C
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1045-1052. PubMed ID: 38101787
[TBL] [Abstract][Full Text] [Related]
12. Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD).
Ceribelli A; Cavazzana I; Franceschini F; Quinzanini M; Rizzini FL; Cattaneo R
Clin Exp Rheumatol; 2008; 26(1):117-20. PubMed ID: 18328157
[TBL] [Abstract][Full Text] [Related]
13. Undifferentiated connective tissue disease in a rheumatology center in Cali, Colombia: clinical features of 94 patients followed for a year.
Guerrero LF; Rueda JC; Arciniegas R; Rueda JM
Rheumatol Int; 2013 Apr; 33(4):1085-8. PubMed ID: 22116525
[TBL] [Abstract][Full Text] [Related]
14. Serological markers in Arabs with lupus nephritis.
Al Attia HM; Al Ahmed YH; Chandani AU
Lupus; 1998; 7(3):198-201. PubMed ID: 9607644
[TBL] [Abstract][Full Text] [Related]
15. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
[TBL] [Abstract][Full Text] [Related]
16. Undifferentiated connective tissue disease: predictors of evolution into definite disease.
García-González M; Rodríguez-Lozano B; Bustabad S; Ferraz-Amaro I
Clin Exp Rheumatol; 2017; 35(5):739-745. PubMed ID: 28770704
[TBL] [Abstract][Full Text] [Related]
17. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
[TBL] [Abstract][Full Text] [Related]
18. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.
Franceschini F; Calzavara-Pinton P; Valsecchi L; Quinzanini M; Zane C; Facchetti F; Airò P; Cattaneo R
Adv Exp Med Biol; 1999; 455():167-71. PubMed ID: 10599339
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to Ro/SS-A and La/SS-B in systemic lupus erythematosus and other autoimmune disorders.
Pradhan VD; Badakere SS; Bichile LS; Dolas MP
J Assoc Physicians India; 2002 Jun; 50():762-5. PubMed ID: 12240838
[TBL] [Abstract][Full Text] [Related]
20. Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus.
Menéndez A; Gómez J; Caminal-Montero L; Díaz-López JB; Cabezas-Rodríguez I; Mozo L
ScientificWorldJournal; 2013; 2013():832789. PubMed ID: 24294139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
